<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966823</url>
  </required_header>
  <id_info>
    <org_study_id>G080077</org_study_id>
    <nct_id>NCT00966823</nct_id>
  </id_info>
  <brief_title>Fetal Tracheal Balloon Study in Diaphragmatic Hernia</brief_title>
  <official_title>Phase 2 Fetal Tracheal Balloon (IDE G080077) Study in Diaphragmatic Hernia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this phase 2 limited study is to examine whether prenatal intervention correct
      the lung underdevelopment associated with severe diaphragmatic hernia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Congenital diaphragmatic hernia (CDH) has traditionally been associated with very high
      mortality rates. Most infants died of pulmonary hypoplasia and severe pulmonary hypertension.
      This led to correction of CDH and pulmonary hypoplasia before birth. Unfortunately, maternal
      morbidity of open fetal surgery was significant and fetal mortality was very high (&gt;60%).
      Moreover, the results of postnatal therapy for CDH improved dramatically, from less than 20%
      survival several decades ago to more than 70% today.

      Fetal intervention has evolved as well, to a minimally invasive approach that involves a
      single endoscopic port and occlusion of the fetal trachea. While this has considerably
      decreased the morbidity and fetal mortality of the in utero procedure, its results do not
      exceed the overall (i.e., non-stratified) results of contemporary postnatal treatment. Most
      recently, a multicentric cooperative study under (Eurofoetus) has conducted a clinical trial
      comparing postnatal treatment with endoscopic fetal tracheal occlusion for the most severe
      forms of CDH. Results of the Eurofoetus trial and of a recent retrospective review involving
      European and North-American centers have shown the following: 1) It is possible to identify a
      specific subgroup of fetuses with CDH in whom survival can be predicted to be less than 10%,
      despite all current methods of postnatal treatment, 2) Survival of fetuses with predicted
      postnatal survival of 8% was &gt;50% following endoscopic fetal tracheal occlusion, and 3) Fetal
      tracheal occlusion in that group resulted in an increase in lung size (LHR), from an average
      of 0.7 pre-intervention, to 1.7 post-intervention.

      Based on the available research literature, the results of the Eurofoetus trial, and this
      institution's experience with endoscopic fetal surgery, we hypothesize that in the highest
      risk group of fetuses with congenital diaphragmatic hernia, where chances of survival is
      estimated at less than 10%, endoscopic fetal tracheal occlusion in late second trimester,
      with reversal of occlusion in mid-third trimester, allows catch-up lung growth and maturation
      and converts the condition into one with intermediate to good prognosis (predicted survival
      50-60%). We propose to offer this form of treatment, under an FDA-approved Investigational
      Device Exemption (G080077), to eligible patients, on a case-by-case basis, after discussion
      before a multidisciplinary board.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Device no longer available
  </why_stopped>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Newborn Survival at Birth</measure>
    <time_frame>Newborn period (1 day)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Newborn Survival at 30 Days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Complications</measure>
    <time_frame>Intervention to 30 days postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal Morbidity</measure>
    <time_frame>Intervention to delivery</time_frame>
    <description>Fetal morbidity, fetal mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With In Utero Lung Growth (LHR) &gt;1.4</measure>
    <time_frame>Intervention to 2 weeks post-intervention</time_frame>
    <description>Inclusion criterion for the study is LHR&lt;0.9 (extreme pulmonary hypoplasia). Given that LHR is relatively constant during 2nd and 3rd trimester of gestation, &quot;In utero lung growth&quot; is defined as LHR&gt;1.4 (definition of mild/moderate pulmonary hypoplasia) within 2 weeks of intervention.
Outcome measure = number of participants with LHR&gt;1.4 at 2 weeks post-intervention</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Diaphragmatic Hernia</condition>
  <condition>Lung Disease</condition>
  <arm_group>
    <arm_group_label>Detachable balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Fetuses treated with endoscopic tracheal occlusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fetal tracheal obstruction with detachable balloon (device)</intervention_name>
    <description>Fetal tracheal obstruction with detachable balloon (device): Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
    <arm_group_label>Detachable balloon</arm_group_label>
    <other_name>Goldvalve Balloon, nFocus Neuromedical, Inc.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancies

          -  Isolated congenital diaphragmatic hernia

          -  Normal karyotype (amniocentesis)

          -  Initial diagnosis before 26 weeks gestation

          -  Competent cervix

          -  Severity of CDH: lung-to-head ratio (LHR) â‰¤0.8 at 22-26 weeks gestation

          -  Liver herniation in the chest

          -  Informed consent

        Exclusion Criteria:

          -  Preterm labor, premature rupture of membranes or amniotic leak

          -  Significant maternal morbidity

          -  Minor (&lt;18 years)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois I Luks, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rhode Island Hospital/Women &amp; Infants' Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://med.brown.edu/pedisurg/Fetal/FetalProgramCDH.html</url>
    <description>Information about congenital diaphragmatic hernia - The Fetal Treatment Program</description>
  </link>
  <link>
    <url>http://www.fetal-program.org</url>
    <description>The Fetal Treatment Program Home</description>
  </link>
  <reference>
    <citation>Bealer JF, Skarsgard ED, Hedrick MH, Meuli M, VanderWall KJ, Flake AW, Adzick NS, Harrison MR. The 'PLUG' odyssey: adventures in experimental fetal tracheal occlusion. J Pediatr Surg. 1995 Feb;30(2):361-4; discussion 364-5.</citation>
    <PMID>7738765</PMID>
  </reference>
  <reference>
    <citation>Luks FI, Roggin KK, Wild YK, Piasecki GJ, Rubin LP, Lesieur-Brooks AM, De Paepe ME. Effect of lung fluid composition on type II cellular activity after tracheal occlusion in the fetal lamb. J Pediatr Surg. 2001 Jan;36(1):196-201.</citation>
    <PMID>11150464</PMID>
  </reference>
  <reference>
    <citation>Luks FI, Wild YK, Piasecki GJ, De Paepe ME. Short-term tracheal occlusion corrects pulmonary vascular anomalies in the fetal lamb with diaphragmatic hernia. Surgery. 2000 Aug;128(2):266-72.</citation>
    <PMID>10923003</PMID>
  </reference>
  <reference>
    <citation>Wild YK, Piasecki GJ, De Paepe ME, Luks FI. Short-term tracheal occlusion in fetal lambs with diaphragmatic hernia improves lung function, even in the absence of lung growth. J Pediatr Surg. 2000 May;35(5):775-9.</citation>
    <PMID>10813348</PMID>
  </reference>
  <reference>
    <citation>De Paepe ME, Johnson BD, Papadakis K, Luks FI. Lung growth response after tracheal occlusion in fetal rabbits is gestational age-dependent. Am J Respir Cell Mol Biol. 1999 Jul;21(1):65-76.</citation>
    <PMID>10385594</PMID>
  </reference>
  <reference>
    <citation>De Paepe ME, Papadakis K, Johnson BD, Luks FI. Fate of the type II pneumocyte following tracheal occlusion in utero: a time-course study in fetal sheep. Virchows Arch. 1998 Jan;432(1):7-16.</citation>
    <PMID>9463582</PMID>
  </reference>
  <reference>
    <citation>De Paepe ME, Johnson BD, Papadakis K, Sueishi K, Luks FI. Temporal pattern of accelerated lung growth after tracheal occlusion in the fetal rabbit. Am J Pathol. 1998 Jan;152(1):179-90.</citation>
    <PMID>9422535</PMID>
  </reference>
  <reference>
    <citation>Papadakis K, Luks FI, De Paepe ME, Piasecki GJ, Wesselhoeft CW Jr. Fetal lung growth after tracheal ligation is not solely a pressure phenomenon. J Pediatr Surg. 1997 Feb;32(2):347-51.</citation>
    <PMID>9044151</PMID>
  </reference>
  <reference>
    <citation>Luks FI, Deprest JA, Gilchrist BF, Peers KH, van der Wildt B, Steegers EA, Vandenberghe K. Access techniques in endoscopic fetal surgery. Eur J Pediatr Surg. 1997 Jun;7(3):131-4.</citation>
    <PMID>9241495</PMID>
  </reference>
  <reference>
    <citation>Jani JC, Nicolaides KH, GratacÃ³s E, Valencia CM, DonÃ© E, Martinez JM, Gucciardo L, Cruz R, Deprest JA. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2009 Sep;34(3):304-10. doi: 10.1002/uog.6450.</citation>
    <PMID>19658113</PMID>
  </reference>
  <reference>
    <citation>Deprest JA, Flemmer AW, Gratacos E, Nicolaides K. Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2009 Feb;14(1):8-13. doi: 10.1016/j.siny.2008.08.010. Epub 2008 Oct 8.</citation>
    <PMID>18845492</PMID>
  </reference>
  <reference>
    <citation>Yang SH, Nobuhara KK, Keller RL, Ball RH, Goldstein RB, Feldstein VA, Callen PW, Filly RA, Farmer DL, Harrison MR, Lee H. Reliability of the lung-to-head ratio as a predictor of outcome in fetuses with isolated left congenital diaphragmatic hernia at gestation outside 24-26 weeks. Am J Obstet Gynecol. 2007 Jul;197(1):30.e1-7.</citation>
    <PMID>17618746</PMID>
  </reference>
  <reference>
    <citation>Luks FI, Carr SR, Muratore CS, O'Brien BM, Tracy TF. The pediatric surgeons' contribution to in utero treatment of twin-to-twin transfusion syndrome. Ann Surg. 2009 Sep;250(3):456-62. doi: 10.1097/SLA.0b013e3181b45794.</citation>
    <PMID>19644353</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2009</study_first_posted>
  <results_first_submitted>July 3, 2015</results_first_submitted>
  <results_first_submitted_qc>May 23, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 30, 2017</results_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rhode Island Hospital</investigator_affiliation>
    <investigator_full_name>Francois Luks</investigator_full_name>
    <investigator_title>Francois I. Luks, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Diaphragm</keyword>
  <keyword>Trachea</keyword>
  <keyword>Lung development</keyword>
  <keyword>Lung growth</keyword>
  <keyword>Tracheal occlusion</keyword>
  <keyword>ECMO</keyword>
  <keyword>Neonatal death</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Hernia, Diaphragmatic</mesh_term>
    <mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1 participant met inclusion criteria and was enrolled, but was excluded immediately before intervention (active labor), and was therefore excluded from the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Detachable Balloon</title>
          <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Detachable Balloon</title>
          <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Newborn Survival at Birth</title>
        <time_frame>Newborn period (1 day)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Detachable Balloon</title>
            <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
          </group>
        </group_list>
        <measure>
          <title>Newborn Survival at Birth</title>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Newborn Survival at 30 Days</title>
        <time_frame>30 days</time_frame>
        <population>1 of 2 enrolled participants (fetuses) survived until birth (Primary outcome). This 1 participant (infant) also survived at 30 days (secondary outcome).</population>
        <group_list>
          <group group_id="O1">
            <title>Detachable Balloon</title>
            <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
          </group>
        </group_list>
        <measure>
          <title>Newborn Survival at 30 Days</title>
          <population>1 of 2 enrolled participants (fetuses) survived until birth (Primary outcome). This 1 participant (infant) also survived at 30 days (secondary outcome).</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Complications</title>
        <time_frame>Intervention to 30 days postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Detachable Balloon</title>
            <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Complications</title>
          <units>occurrences</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fetal Morbidity</title>
        <description>Fetal morbidity, fetal mortality</description>
        <time_frame>Intervention to delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Detachable Balloon</title>
            <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
          </group>
        </group_list>
        <measure>
          <title>Fetal Morbidity</title>
          <description>Fetal morbidity, fetal mortality</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With In Utero Lung Growth (LHR) &gt;1.4</title>
        <description>Inclusion criterion for the study is LHR&lt;0.9 (extreme pulmonary hypoplasia). Given that LHR is relatively constant during 2nd and 3rd trimester of gestation, &quot;In utero lung growth&quot; is defined as LHR&gt;1.4 (definition of mild/moderate pulmonary hypoplasia) within 2 weeks of intervention.
Outcome measure = number of participants with LHR&gt;1.4 at 2 weeks post-intervention</description>
        <time_frame>Intervention to 2 weeks post-intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Detachable Balloon</title>
            <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With In Utero Lung Growth (LHR) &gt;1.4</title>
          <description>Inclusion criterion for the study is LHR&lt;0.9 (extreme pulmonary hypoplasia). Given that LHR is relatively constant during 2nd and 3rd trimester of gestation, &quot;In utero lung growth&quot; is defined as LHR&gt;1.4 (definition of mild/moderate pulmonary hypoplasia) within 2 weeks of intervention.
Outcome measure = number of participants with LHR&gt;1.4 at 2 weeks post-intervention</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data collected up to 6 months postnatally</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Detachable Balloon</title>
          <description>Fetuses treated with endoscopic tracheal occlusion
Fetal tracheal obstruction with detachable balloon (device): - Endoscopic placement of a detachable balloon in the fetal trachea at 28-30 weeks gestation.
- Ultrasound-guided puncture of balloon or, if not feasible, repeat endoscopic tracheoscopy with puncture and retrieval of the balloon at 34 weeks gestation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Francois I. Luks, MD, PhD</name_or_title>
      <organization>Rhode Island Hospital</organization>
      <phone>401-228-0556</phone>
      <email>Francois_Luks@brown.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

